Dr Marrero is a consultant with and serves on the advisory boards for Onyx Pharmaceuticals and Bayer. Dr Maluccio has no relevant financial relationships with commercial interests to disclose. Ms McCurdy is on the speakers' bureau for Onyx Pharmaceuticals. Dr Abou-Alfa and/or his spouse serve as a consultant for Aduro Biotech, Astellas Pharma US, AstraZeneca, Bayer, Celgene, Celsion, Eli Lilly and Company, Exelixis, Genentech, IntegraGen, Jennerex Biotherapeutics, MedImmune, Novartis, Pharmacyclics, Roche, sanofi-aventis, Silenseed, and Vicus Therapeutics. He and/or his spouse have received research grants from Abbott Laboratories, Amgen, Bayer, Eli Lilly and Company, Exelixis, Genentech, Momenta Pharmaceuticals, Myriad Genetics, Novartis, OncoMed Pharmaceuticals, Polaris Pharmaceuticals, Roche, sanofi-aventis, and Vicus Therapeutics.
|Original language||English (US)|
|Number of pages||12|
|Issue number||2 SUPPL|
|State||Published - Apr 2014|
ASJC Scopus subject areas